143 related articles for article (PubMed ID: 10079003)
1. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor.
Gupta P; Scatchard J; Napier C; McHarg A; Wallis R
Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels.
van den Broek RW; MaassenVanDenBrink A; de Vries R; Bogers AJ; Stegmann AP; Avezaat CJ; Saxena PR
Eur J Pharmacol; 2000 Oct; 407(1-2):165-73. PubMed ID: 11050304
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
[TBL] [Abstract][Full Text] [Related]
4. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
5. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.
Parsons AA; Whalley ET; Feniuk W; Connor HE; Humphrey PP
Br J Pharmacol; 1989 Feb; 96(2):434-40. PubMed ID: 2538194
[TBL] [Abstract][Full Text] [Related]
7. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
Perren MJ; Feniuk W; Humphrey PP
Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
[TBL] [Abstract][Full Text] [Related]
9. Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries.
Parsons AA; Raval P; Smith S; Tilford N; King FD; Kaumann AJ; Hunter J
J Cardiovasc Pharmacol; 1998 Aug; 32(2):220-4. PubMed ID: 9700983
[TBL] [Abstract][Full Text] [Related]
10. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels.
MaassenVanDenBrink A; van den Broek RW; de Vries R; Bogers AJ; Avezaat CJ; Saxena PR
Neurology; 2000 Nov; 55(10):1524-30. PubMed ID: 11094108
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.
Cortijo J; Martí-Cabrera M; Bernabeu E; Domènech T; Bou J; Fernández AG; Beleta J; Palacios JM; Morcillo EJ
Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295
[TBL] [Abstract][Full Text] [Related]
12. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
[TBL] [Abstract][Full Text] [Related]
13. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
14. Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha).
Cohen ML; Schenck K
Br J Pharmacol; 2000 Oct; 131(3):562-8. PubMed ID: 11015308
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.
Sumner MJ; Feniuk W; McCormick JD; Humphrey PP
Br J Pharmacol; 1992 Mar; 105(3):603-8. PubMed ID: 1320980
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
Johnson DE; Rollema H; Schmidt AW; McHarg AD
Eur J Pharmacol; 2001 Aug; 425(3):203-10. PubMed ID: 11513839
[TBL] [Abstract][Full Text] [Related]
17. Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction.
Galzin AM; Delahaye M; Hoornaert C; McCort G; O'Connor SE
Eur J Pharmacol; 2000 Sep; 404(3):361-8. PubMed ID: 10996601
[TBL] [Abstract][Full Text] [Related]
18. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
19. Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562.
Maassen VanDenBrink A; Reekers M; Bax WA; Saxena PR
Pharmacol Toxicol; 2000 Jun; 86(6):287-90. PubMed ID: 10895993
[TBL] [Abstract][Full Text] [Related]
20. Bovine isolated middle cerebral artery contractions to antimigraine drugs.
Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]